GlassScriptPhysician profile
James A Killeffer
NPI 1851333728
$164,913.55
in general payments reported to CMS, 2019-2025
19 companies · $69.88 in 2025
The $69.88 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163K · 2020: $367 · 2021: $585 · 2022: $444 · 2023: $426 · 2024: $219 · 2025: $69.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $695 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $695.09 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arkis Biosciences INC | $162,551.15 | 2019 | |
| Sanara Medtech INC. | $941.94 | 2020-2024 | Celleraterx |
| Stryker Corporation | $357.33 | 2021-2023 | Everest Spinal System, Ozark Cervical Plate System, Capri Corpectomy Cage System |
| Zimvie INC. | $206.96 | 2022-2024 | |
| Zimmer Biomet Holdings, INC. | $177.21 | 2019-2022 | |
| Spineology INC. | $118.25 | 2022 | |
| Medtronic USA, INC. | $95.34 | 2019 | |
| Integra Lifesciences Corporation | $82.77 | 2019-2025 | Cusa Clarity, Codman Hakim, Codman Certas |
| Csl Behring | $52.65 | 2019-2024 | Kcentra |
| Medtronic, INC. | $48.55 | 2023-2024 | Mazor X System, Catalyft Pl Expandable Interbody System |
| Spine Wave, INC. | $44.66 | 2021 | |
| Highridge Medical LLC | $41.80 | 2024 | Trelloss-C Sa |
| Innovation Technologies INC | $41.74 | 2021 | |
| Misonix INC | $35.85 | 2019-2020 | |
| Wound Management Technologies, INC | $31.91 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap, INC. | $26.26 | 2024 | Aesculap |
| Arbor Pharmaceuticals, INC. | $22.03 | 2021 | |
| Ethicon US, LLC | $21.41 | 2023 | Vistaseal |
| Abbvie INC. | $15.74 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,192,376.68 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Killeffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.